Price Chart

Profile

Cormedix Inc is a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases. The Company’s focus is on the commercialization of its product, DefenCath, in the United States (U.S.) and other key markets.
URL https://www.cormedix.com
Investor Relations URL N/A
HQ State/Province New Jersey
Sector Health Care
Industry Pharmaceuticals
Equity Style Small Cap/Growth
Next Earnings Release Mar. 12, 2025 (est.)
Last Earnings Release Oct. 30, 2024
Next Ex-Dividend Date N/A
Last Ex-Dividend Date N/A

Profile

Cormedix Inc is a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases. The Company’s focus is on the commercialization of its product, DefenCath, in the United States (U.S.) and other key markets.
URL https://www.cormedix.com
Investor Relations URL N/A
HQ State/Province New Jersey
Sector Health Care
Industry Pharmaceuticals
Equity Style Small Cap/Growth
Next Earnings Release Mar. 12, 2025 (est.)
Last Earnings Release Oct. 30, 2024
Next Ex-Dividend Date N/A
Last Ex-Dividend Date N/A